TFBS Bioscience Inc. (6939.TWO)

TWD 32.3

(1.1%)

Annual Cash Flows

(In TWD)
Breakdown 2023 2022 2021 2020
Operating Cash Flow 36.52 Million 78.71 Million 21.02 Million 29.44 Million
Net Income 4.77 Million 30.71 Million 7 Million 334 Thousand
Depreciation & Amortization 58.77 Million 36.97 Million 25.44 Million 25.21 Million
Deferred income taxes - - - -
Stock-based compensation 14.28 Million 6.64 Million 1.62 Million 563 Thousand
Change in working capital -32.79 Million -590 Thousand -13.04 Million 3.32 Million
Other non-cash items -10.58 Million -3.27 Million -35 Thousand 130 Thousand
Investing Cash Flow -57.63 Million -104.74 Million -19.35 Million -12.8 Million
Investments in PPE -55.88 Million -49.83 Million -19.04 Million -13.34 Million
Acquisitions - - - -
Investment purchases - -50 Million - -
Sales/Maturities of investments - - - -
Other Investing Activities -1.75 Million -4.91 Million -316 Thousand 537 Thousand
Financing Cash Flow -25.99 Million 761.55 Million 163.11 Million -6.86 Million
Debt repayment - - - -
Dividends payments -3.34 Million - - -
Common Stock Repurchased - - - -
Common Stock Issuance 7.53 Million 778.01 Million 119.01 Million -
Other Financing Activities 714 Thousand - 50.15 Million -
Accounts receivables -1.35 Million - - -
Accounts payables - - - -
Inventory -3.15 Million 166 Thousand -4.17 Million -
Other working capital -28.29 Million - - -
Cash at beginning of period 976.43 Million 240.91 Million 76.13 Million 66.36 Million
Cash at end of period 929.34 Million 976.43 Million 240.91 Million 76.13 Million
Capital Expenditure -55.88 Million -49.83 Million -19.04 Million -13.34 Million
Effect of forex changes on cash 7000.00 - - -
Net cash flow / Change in cash -47.09 Million 735.52 Million 164.77 Million 9.77 Million
Free Cash Flow -19.35 Million 28.88 Million 1.98 Million 16.1 Million

Cash Flow Charts